BARASCH RICHARD A 4
4 · Oncology Institute, Inc. · Filed Jun 20, 2025
Insider Transaction Report
Form 4
BARASCH RICHARD A
Director
Transactions
- Conversion
Class A Common Equivalent Preferred Stock
2025-06-17−1,595→ 0 totalExercise: $0.00→ Common Stock (159,500 underlying) - Conversion
Common Stock
2025-06-18+620,400→ 2,555,541 total(indirect: By Trust) - Conversion
Common Stock
2025-06-17+159,500→ 1,935,141 total - Conversion
Class A Common Equivalent Preferred Stock
2025-06-18−6,204→ 0 total(indirect: By Trust)Exercise: $0.00→ Common Stock (620,400 underlying)
Footnotes (4)
- [F1]Represents the conversion of shares of Class A Common Equivalent Preferred Stock, par value $0.0001 (the "Preferred Stock") into shares of the Issuer's common stock, par value $0.0001 (the "Common Stock") in accordance with and pursuant to the Certificate of Designation of Preferences, Rights and Limitations of Series A Common Stock Equivalent Convertible Preferred Stock (the "Certificate of Designation").
- [F2]Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion.
- [F3]Securities are owned by Helen Barasch Family Trust #1, an affiliate of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein.
- [F4]Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date.